Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

RELATED-PARTY TRANSACTIONS

v3.22.1
RELATED-PARTY TRANSACTIONS
12 Months Ended
Dec. 31, 2021
Related Party Transactions [Abstract]  
RELATED-PARTY TRANSACTIONS

16. RELATED-PARTY TRANSACTIONS

Key management personnel are Titan Medical Inc.'s, President & Chief Executive Officer, Chief Financial Officer and Senior Vice-President R&D, General Counsel & Corporate Secretary.

The executive compensation expense to the key management personnel and the Board is as follows:

Year ended December 31,

2021

2020

2019

$

$

$

Salaries and Benefits

1,570

670

803

Board fees

294

132

199

Stock-based compensation

3,093

455

693

Balance at December 31, 2021

4,957

1,257

1,695